Search Results

Terumo Neuro’s Sofia 88 Support Catheter Launched in United States

May 13, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia 88 neurovascular support catheter.

Vesalio Announces CE Mark Approval for NeVa VS and NeVa 3.0 mm

February 10, 2026—Vesalio announced CE Mark certification and the European commercial launch of its NeVa VS for cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH) and NeVa 3.0 mm thrombectomy system for stroke, along with an additional FDA 510(k) clearance expanding indications for its neurovascular and peripheral aspiration catheters to include distal access, according to the company’s press release.

Enrollment Begins in MARRS Pivotal Trial of Perfuze Millipede System

November 7, 2023—Perfuze, an Ireland-based medical device company developing technology to treat acute ischemic stroke, recently announced commencement of enrollment in its pivotal MARRS clinical study.

Viz.ai Debuts Viz ANX Cerebral Aneurysm Detection Solution

November 17, 2021—Viz.ai announced the introduction of Viz ANX, the company’s artificial intelligence (AI)–powered suspected cerebral aneurysm detection and care coordination platform.

Viz.Ai Artificial Intelligence Platform Demonstrates Improved Stroke Outcomes and Increased Trial Enrollment

March 19, 2021—Viz.Ai announced the presentation of data at International Stroke Conference 2021 that show the impact of the company’s artificial intelligence-powered platform to better coordinate care for acute ischemic and hemorrhagic stroke and improve clinical trial recruitment.

J&J MedTech Launches Cereglide 42 and 57 Aspiration Catheters for Stroke

February 26, 2026—Johnson & Johnson MedTech announced the United States launch of the Cereglide 42 and Cereglide 57 aspiration catheters and the Innerglide 7 delivery aid as part of its aspiration-first stroke portfolio.

SVIN’s MT-2020 Plus Study Analyzes Global Access to Mechanical Thrombectomy for Stroke Patients

March 17, 2023—The Society of Vascular and Interventional Neurology (SVIN) recently announced that it has released a first-ever global analysis of access to mechanical thrombectomy (MT) for treatment of large vessel occlusion stroke.